Claims for Patent: 6,162,648

Summary for Patent: 6,162,648

Title:	Purification of Indium 111
Abstract:	Undesirable metal cation contaminants, including cadmium, can be removed from a solution containing Indium-111, on a bed of an anion exchange resin. The thus purified solution can be stored and transported in a polypropylene vial, to prevent the possibility of cadmium entering the solution from a glassware wall and of Indium from being lost from the solution by chemically reacting with a glassware wall. The vial can be sealed with a rubber stopper which has a polytetrafluroethylene coating facing the solution to prevent the possibility of contaminants which could interfere with later uses of the Indium-111 from leaching into the solution from the rubber stopper. Recipients of the Indium-111-containing vial can be provided with a prepackaged column of the anion exchange resin to enable such recipients to remove the cadmium which accumulated in the solution as a product of radioactive decay during shipment.
Inventor(s):	Maloney; Thomas J. (Friendswood, TX), Camp, Jr.; Arthur E. (Fresno, TX)
Assignee:	Iso-Tex Diagnostics, Inc. (Friendswood, TX)
Application Number:	09/161,211
Patent Claims:	1. A process for purifying a dilute HCl solution of Indium-111 which contains undesirable cadmium cation contaminant, said process comprising contacting said solution with a bed of an anion exchange resin under conditions to retain the cadmium cation contaminant in the bed, wherein the bed of resin forms a strong anion exchange inside a column and the contacting occurs by flowing the solution through the column, and the column is prepared for purifying the solution of Indium-111 by flowing an HCl solution through the column to form an HCl treated column and then flowing an NaCl solution through the HCl treated column to form an NaCl treated column. 2. A process as in claim 1 further comprising further preparing the column for purifying the solution of Indium-111 by flowing sterile water through the NaCl-treated column. 3. A process as in claim 2 wherein the column has an upper end and a lower end, said process further comprising injecting a gas into an upper end of the column to push the solution of Indium 111 through the column. 4. A process as in claim 3 wherein the anion exchange resin is in powdered form. 5. A process as in claim 4 wherein the anion exchange resin comprises particles having a particle size predominantly in the range of about to 100 to about 200 mesh. 6. A process as in claim 5 wherein the anion exchange resin is strongly basic anion, 8% cross linking.

Details for Patent 6,162,648

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23